RhumbLine Advisers’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.54M | Buy |
|
|||||
|
2025
Q2 | $2.62M | Buy |
|
|||||
|
2025
Q1 | $1.9M | Buy |
|
|||||
|
2024
Q4 | $2.26M | Buy |
|
|||||
|
2024
Q3 | $2.05M | Buy |
|
|||||
|
2024
Q2 | $2.11M | Buy |
|
|||||
|
2024
Q1 | $2.26M | Buy |
|
|||||
|
2023
Q4 | $2.16M | Sell |
|
|||||
|
2023
Q3 | $1.69M | Sell |
|
|||||
|
2023
Q2 | $1.93M | Buy |
|
|||||
|
2023
Q1 | $1.4M | Buy |
|
|||||
|
2022
Q4 | $1.58M | Buy |
|
|||||
|
2022
Q3 | $2.18M | Buy |
|
|||||
|
2022
Q2 | $1.54M | Buy |
|
|||||
|
2022
Q1 | $887K | Buy |
|
|||||
|
2021
Q4 | $2.04M | Buy |
|
|||||
|
2021
Q3 | $582K | Buy |
|
|||||
|
2021
Q2 | $760K | Buy |
|